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The  production  of  humoral  antibody  to  sheep  erythrocytes  (SRBC) 1 after  the 
primary immunization of mice has been shown by a  number  of workers to be sup- 
pressed  by  the  presence  of  passively  administered  anti-SRBC  serum  during  the 
immunization (1-3 and for review see 4). 
The development of antibody-producing or plaque-forming cells (PFC) in response 
to SRBC is a complex event both in vivo and in vitro involving a cooperation between 
several cell populations. One population, the thymus-derived lymphocytes (T-cells), 
is distinguished by the thymus-specific surface antigen, theta (5, 6). A small portion 
of these cells have receptors specific for determinants on the SRBC  (SRBC-specific 
T-cells) and appear to be identical to a  fraction of the SRBC  rosette-forming cells 
(3,  7-9). The number  of these cells increases markedly in the  spleens of mice after 
immunization with  SRBC  (3,  7,  10,  11).  T-cells have  been  implicated in  the phe- 
nomenon of immunological memory (3, 7, 12, 13). There is a great weight of evidence 
that T-cells are involved in cellular immune responses, and very recently Cerottini 
et al. have shown that the cytotoxic activity of immune lymphocytes is abolished by 
pretreatment with anti-0-serum and complement (14). 
A second population of cells involved in the response to SRBC, generally referred 
to as the bone marrow-derived lymphocytes (B-cells) (for review see [15]),  contains 
precursor cells with receptors specific for SRBC determinants (SRBC-specific B-cells) 
(8). After interaction with antigen and SRBC-specific T-cells these precursors divide, 
rapidly  developing into  PFC  producing antibody specific for  SRBC  determinants 
(anfi-SRBC PFC)  (10,  16-18). It is the development of these PFC from precursors 
that is suppressed by passively administered anti-SRB  C serum. 
There is some evidence that the antigen-stimulated increase in T-cells is not nearly 
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as sensitive as the development of antibody-producing cells to suppression by anti- 
serum.  Priming for  phenomena which  involve cellular immunity, such  as  delayed 
hypersensitivity, can be relatively insensitive to antiserum (19),  as can priming for 
immunological memory (3, 20). In addition, Greaves et al. have shown that the anti- 
gen-stimulated increase in the SRBC rosette-forming cells  of mouse spleens is less 
susceptible to  suppression by anti-SRBC serum  than is  the  development of  anti- 
SRBC PFC (3). 
Kettman and Dutton have described a method which allows  the quantitation of 
SRBC-specific  T-cells on the basis of their function, i.e.,  their ability to participate 
in the development of B-cell  precursors into PFC  (11, 21).  Spleen cell  suspensions 
cultured with the trinitrophenyl (TNP) hapten coupled to the carrier SRBC (TNP- 
SRBC) not only develop PFC specific for SRBC determinants but also PFC specific 
for TNP. As in the case  of SRBC-speeific  B-cells,  TNP-specific B-cells  require the 
cooperation of  T-cells in order  to  develop into anti-TNP-PFC. The participating 
T-cells in this ease, however,  show a specificity which is largely if not entirely for the 
SRBC  carrier and are  indistinguishable from  the  SRBC-specific  T-cells which co- 
operate in the development of anti-SRBC-PFC. SRBC-specific  T-cells are limiting 
in the spleens of normal mice, as shown by the greatly enhanced anti-TNP response 
of spleens from mice which have been primed with SRBC carrier. The degree  of en- 
hancement becomes an effective assay for their function. 
Using this  technique we  have  been able  to  show  that  anti-SRBC  serum 
administered passively to mice in an amount sufficient to severely suppress the 
appearance of anti-SRBC-PFC in the spleen has little effect on the stimulation 
of SRBC-specific T-cells. 
Materials and Methods 
M/ce.--8-12-wk  old hybrid mice (BDF1) from C57BL/6  female X  DBA/2 male were 
used in all experiments. Both male and female mice  were used, but within a given experiment 
mice of the same sex and age were used. 
AnJigens.--Sheep and horse erythrocytes  (SRBC and HRBC)  were obtained  from the 
Colorado Serum Company, Denver,  Colo. Trinitrophenylated  erythrocytes  were prepared 
by the method of Rittenberg and Pratt (22) as modified by Kettman and Dutton (21). Im- 
munizations were performed by tail vein injection. 
Antisera.--Mouse anti-SRBC serum was prepared by bleeding mice 10 days after the last 
of three weekly injections of 2 ;< 10  s SRBC. A pool of antisera was made from 20 mice and 
used in all experiments reported here. The hemolytic titer of this pool against SRBC was 
1/2048; the hemagglutination titer was 1/256. 
Purified mouse anti-TNP antibody was the generous gift of Dr. Vincent Reed. It was iso- 
lated from hyperimmune mouse anti-TNP-hemocyanin  sermn by use of the immunoadsorbant 
TNP-Sephadex (23) and did not cross-react with SRBC. 
Assay.---Cells producing antibody specific for SRBC determinants were enumerated by the 
Jerne hemolytic plaque assay  (24) as modified by Mishell and Dutton (25). TNP-specific 
antibody-producing cells were assayed by the method of Rittenberg and Pratt (22) as modified 
by Kettman and Dutton (21) using TNP coupled to HRBC. 
Cultures.--Spleen cell suspensions were cultured  by the  method of Mishell and Dutton 
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RESULTS 
Antisera, raised by repeated immunization with SRBC, were pooled from 20 
mice and tested for the ability to suppress the primary humoral IgM response 
of mice to SRBC. The results of several experiments, shown in Table I, demon- 
strate that small amounts of the anti-SRBC  serum administered passively to 
mice were very effective in preventing the appearance of IgM-producing anti- 
SRBC-PFC  ill  the spleen. Virtually complete suppression was obtained with 
1/~1 and 82 % suppression with only 0.2 ~1. This pool was used in all subsequent 
experiments reported here. 
In order to see if passively administered anti-SRBC serum is also capable of 
preventing  the  antigen-induced  increase in  SRBC-specific T-cells,  spleen  cell 
suspensions from mice which had been primed with SRBC  in the presence or 
absence  of  anti-SRBC  serum  were  cultured  with  the  antigen,  TNP-SRBC. 
The results of several experiments are shown in Table II. As reported earlier 
by Kettman  and Dutton  (11),  it Call be seen that priming of mice with  the 
carrier, SRBC, leads to a large increase in the number of SRBC-specific T-cells 
in the spleen within 3-4 days, as measured by the 4 to nearly 20-fold enhance- 
ment  of  the  anti-TNP  response  in  vitro.  The presence  of anti-SRBC  serum 
during the priming did not diminish this enhancement, i.e., under the conditions 
of  these  experiments  anti-SRBC  serum  is  unable  to  prevent  the  antigen- 
stimulated increase in SRBC-specific T-cells. 
There is, however, a body of evidence that the antigen dose required for the 
production  of humoral  antibody is much higher  than  that  necessary for the 
stimulation of T-cells (3, 26). In fact Falkoff and Kettman have shown in this 
system that  the  optimal SRBC  priming dose for  an  enhanced  anti-TNP  re- 
sponse in vitro is 100-fold less than the optimal dose for the production of anti- 
SRBC-PFC. ~ The inability of anti-SRBC serum to suppress the stimulation of 
SRBC-specific T-cells would be explained if the action of the antiserum was to 
lower the effective antigen dose in the animal to a  level that is far below the 
optimal for PFC  development but  still  well  in  the  optimal  range  for T-cell 
stimulation. 
To examine this possibility it was necessary to test the effect of anti-SRBC 
serum in a  range of antigen that is already limiting for T-cells. Dose-response 
studies  for T-cell stimulation  were  performed over a  wide  range  of priming 
antigen doses in the presence and absence of passively transferred anti-SRBC 
serum. The results of a  representative  (one of four) experiment  are  shown  in 
Fig. 1 a and b. As shown by Falkoff and Kettman,  2 the optimal SRBC priming 
2 Falkoff, R., and J.  R. Kettman. Differential stimulation of precursor ceils and carrier 
specific  thymus-derived cell activity in the in vivo response to heterologous erythrocytes in 
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dose for the stimulation of SRBC-specific T-cells, as measured in the enhanced 
in vitro anti-TNP response (Fig. 1 b), is much lower than that for PFC produc- 
tion  (Fig.  1 a).  In fact very low priming doses fail to produce any detectable 
anti-SRBC-PFC,  but still effect considerable T-cell priming. The presence of 
TABLE  I 
The  Suppressive  Effect  of Passively  Administered  Anti-SRBC  Serum  on  the  Development  of 
Anti-SRBC-PFC in Mouse Spleens  In Vivo 
Anti-  Anti-SRBC-PFC/106  spleen  cells on day 4 after immunization 
Exp. No.  SRBC  Sup-  serum  Antigen only  Antigen plus  No antigen or  pression 
antiserum  antiserum 
(,1)  (%) 
M18  10.0  98  ±  26  (3)  0.3  ±  0.1  (3)  n.d.  >99 
J21  10.0  474  ±  175  (5)  0.6  ±  0.6  (5)  0.5  ±  0.2  (4)  >99 
J14  2.0  100  (2)  5  (2)  7  (2)  >100 
J17  2.0  517  (2)  4  (2)  <0.4  (2)  >99 
M18  2.0  98  ±  26  (3)  1.3  -4-  4.7  (3)  n.d.  >98 
J21  1.0  474  -4-  175  (5)  16  ±  12  (5)  0.3  ±  0.2  97 
M18  0.2  98  ±  26  (3)  18  -4-  11  (3)  n.d.  82 
Mice were injected with antigen (2  X  107 SRBC)  or antigen plus the indicated dose of 
anti-SRBC serum. After 4 days the animals were sacrificed,  spleen cells suspensions  prepared, 
and the number of anti-SRBC-PFC/106 cells determined. In most experiments a background 
determination was also  made  on  the spleens of mice which received neither antigen nor 
antiserum. The per cent suppression was calculated as the suppressed response minus the 
background divided by the normal response minus the background X  100. Limits are 95% 
confidence levels. The numbers in the parentheses are the numbers of mice/group, n.d.  = 
not determined. 
TABLE  II 
The  Effect  of Passively  Administered  Anti-SRBC  Serum  on  the  Priming  of SRBC-Specific 
T-Cells 
Anti-TNP-PFC/106 recovered  spleen cells  on day 4 
Exp. No.  Priming  before  Anti-SRBC 
culture  Serum  Unprimed  Primed with  Primed  with 
antigen only  antigen  and  antiserum 
~ays)  ~t) 
M18  4  10  n.d.  952  1285 
M18  4  2  n.d.  952  1250 
M3  3  2  54  538  430 
J10  3  2  19  320  287 
M24  4  2  180  733  2500 
J14  4  2  180  840  2800 
J17  4  2  325  2150  2950 
Mice were injected with antigen  (2  X  107  SRBC)  or antigen plus  anti-SRBC  serum. 
After 3 or 4 days spleen cell suspensions were prepared from these primed and from normal, 
unprimed mice, and were cultured with the antigen, TNP-SRBC. After 4  days the No. of 
anti-TNP-PFC/106 recovered spleen cells was determined. I. W.  KAPPLER,  M.  HOFFMANN~  AND  R.  W.  DUTTON  581 
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Fro.  l.  Relation of PFC  development, T-cell priming, and  suppression by antiserum  to 
antigen dose.  Groups of two mice were injected with various doses  of SRBC with  (O)  or 
without (Q) 2 #1 of anfi-SRBC serum.  (a) Mter 4 days  the animals were sacrificed,  pooled 
spleen cell suspensions prepared, and the number of anti-SRBC-PFC/106 cells determined. 
(b)  The suspensions were cultured with the antigen, TNP-SRBC. Mter 4 days the number 
of anti-TNP-PFC/108 recovered cells was determined.  The anti-TNP response of cultures 
from the spleens of unprimed mice is shown for comparison (-----). 
TABLE  nI 
The Suppressive  Effect  of Anti-TNP Antibody  on  the Development  of Anti-SRBC-PFC and 
Anti-TNP-PFC In Vivo 
Immunized with 
PFC/106  spleen cells on day 4 after 
immunization 
Anti-SRB C  Anfi-TNP 
(a)  TNP-SRBC 
(b)  TNP-SRBC -t- anti-TNP 
(c)  TNP-SRBC +  SRBC +  anti-TNP 
243  4-  72  (5)  36  4-  25  (5) 
39  4-  36  (5)  2.6  4-  2.6  (5) 
278  4-  103  (5)  1.6  4-  0.6  (5) 
Groups of mice were injected as follows:  (a) 2 X  107 TNP-SRBC; (b) 2 X  l0  T TNP-SRBC 
and  4  #g anti-TNP  antibody;  (e)  2  X  107 TNP-SRBC, 2  X  l0  T SRBC, and 4  ~g  anti- 
TNP antibody.  After 4  days the animals were sacrificed,  spleen cell suspensions  prepared, 
and  the number  of anti-SRBC  and  anti-TNP-PFC/106  cells determined. Limits are 95% 
confidence levels. The numbers in the parentheses are the numbers of mice/group. 
anti-SRBC  serum  during  the  priming  severely suppresses  the  development  of 
anti-SRBC-PFC  (Fig.  1 a)  but  has  little effect on the  enhancement  of the  in 
vitro  anti-TNP  response  (Fig.  1 b),  indicating  that  even at  a  dose  of antigen 
which is limiting, T-cell stimulation is not inhibited significantly by anti-SRBC 
serum. 
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antigen dose of 2  )<  10  ~ SRBC  the presence of anti-SRBC  serum during the 
priming  apparently  improved the  stimulation  of SRBC-specific T-cells.  The 
impliCations of this observation are considered in the discussion. 
A number of mechanisms have been proposed to explain the suppression of 
the production of humoral  antibody by passively transferred antiserum  (for 
review see reference 4). Table III gives data from an experiment which bears 
on  the  evaluation  of  these  mechanisms.  Mice  were  immunized  with  TNP- 
SRBC. The ability of anti-TNP antibody to suppress the appearance of PFC 
specific for either TNP or SRBC determinants was tested. As the data show, 
anti-TNP  antibody effectively suppresses  the production of both anti-TNP- 
PFC  and anti-SRBC-PFC.  However, if free SRBC is injected together with 
the  TNP-SRBC,  the  anti-TNP-PFC  are  still  suppressed  but  not  the  anti- 
SRBC-PFC. In other words, antibody to a single determinant on an erythrocyte 
is a  necessary and sufficient condition for the suppression of the response to 
other determinants  of the erythrocyte. 
DISCUSSION 
Kettman and Dutton have recently reported a method which allows the in 
vitro  detection of  SRBC-specific T-cells  (11,  21).  The stimulation of mouse 
spleen cell suspensions with the antigen, TNP-SRBC, leads to the development 
of anti-TNP-PFC.  A  successful response is dependent on the cooperation of 
SRBC-specific T-cells with TNP-specific B-cell precursors. Spleen suspensions 
from mice which have been previously immunized with SRBC yield a greatly 
enhanced number of anti-TNP-PFC  in vitro due to the increased number of 
SRBC-specific T-cells. The system provides a method for the assay of these T- 
cells on the basis of their function. 
Using this technique spleens from mice which had been immunized 3-4 days 
previously with SRBC in the presence or absence of passively transfered anti- 
SRBC serum were assayed for SRBC-specific T-cells. The data show that a dose 
of antiserum which severely suppresses the appearance of anti-SRBC-PFC  in 
the  spleen  (Table I)  does not suppress  the antigen-dependent stimulation  of 
SRBC-specific T-cells (Table II). 
These findings are consistent with data from other laboratories. In general, 
priming for immunological memory is more difficult to suppress by the passive 
transfer of antiserum than is the primary humoral response (3, 20). Priming for 
phenomena involving cellular immunity, such as delayed hypersensitivity, can 
be relatively insensitive to suppression by antibody (19). In addition, Greaves 
et al. have recently shown that in mice the antigen-dependent increase in the 
SRB C-specific rosette-forming  cells of the spleen is less susceptible to suppression 
by anti-SRBC serum that is the development of anti-SRBC-PFC (3). 
However, it has also been demonstrated that the antigen dose necessary for 
T-cell stimulation is much lower than that necessary for a humoral response. J.  w.  KAPPLER,  M.  HOFFMANN,  AND  R.  W.  DUTTON  583 
Delayed hypersensitivity and  immunological memory can  be  initiated  with 
doses of antigen which fail to elicit a humoral antibody response (3, 26). Greaves 
et al. have obtained increases in the number of SRBC-specific rosette-forming 
cells of the spleen with antigen doses far below that necessary for the develop- 
ment  of anti-SRBC-PFC.  Finally and most relevant to the results reported 
here, Falkoff and Kettman have obtained significant stimulation of the SRBC- 
specific T-cells, as measured by the enhanced in vitro anti-TNP response, with 
very low SRBC priming doses3 
It was, therefore, possible that the relative insensitivity of T-cell priming to 
antiserum could be explained if the passively administered antiserum lowered 
the effective concentration of the antigen in the animal to a level below that 
necessary for PFC  development but still within the optimal range for T-cell 
priming. 
To test this possibility the effect of antiserum was determined in an antigen 
dose range that was already limiting for T-cell stimulation. Any further lowering 
of the antigen level in the animal caused by the antiserum would now be ex- 
pected to have a marked effect on the stimulation of T-cells. That anti-SRBC 
serum does not prevent the stimulation of SRBC-specific T-cells even in this 
limiting antigen dose range is clearly shown by the results in Fig. 1, leaving the 
escape of T-cells from suppression as yet unexplained. 
It is interesting to note in Table II and Fig.  1 that with a priming dose of 
2 X  107 SRBC the stimulation of SRBC-specific T-cells is apparently improved 
by the presence of anti-SRBC serum during the priming. One explanation for 
this finding is  the possible  existence of competition between B-cells in  their 
cooperation with T-cells in the in vitro assay.  At this high antigen dose the 
production  of anti-SRBC-PFC  in  the  spleen  indicates  an  expansion  of the 
SRBC-specific  B-cell  population.  This  expanded  population  may  compete 
effectively in  vitro  with  the  TNP-specific B-cells  for  the  available  SRBC- 
specific T-cells, thus lowering the  anti-TNP  response.  The presence of anti- 
serum during the priming prevents the expansion of the SRBC-specific B-cells 
and reduces the possible competition. Further data concerning B-cell competition 
for T-cells is reported by Falkoff and Kettman3 
A  number  of mechanisms  have  been proposed to  explain  the  suppressive 
activity of antiserum on antibody-producing cells (for review see reference 4). 
They can  be  classified into  three  general  types,  any  one  of which  may be 
modified to  include  the  lack  of  suppression  of T-cell stimulation.  There  is 
contradictory evidence for and against each of these mechanisms and it may be 
that depending on such factors as the physical properties or concentration of 
antigen, the class or dose of transferred antiserum, the species of animal, etc., 
any or all of the mechanisms may be operating in a particular experiment. 
The first group of mechanisms depends on the regulation of antibody-pro- 
ducing cells by their own products, analogous to the feedback regulation seen 584  EF]~ECT  OF  ANTIBODY  ON  T-  AND  B-DERIVED  LYMPI-IOCYTES 
in  many  enzyme  systems. In this  scheme antibody  or  an  antigen-antibody 
complex is capable of delivering a suppressive signal to antigen-specific B-cells 
which  can be  distinguished  from the signal from antigen alone. This type of 
mechanism has been proposed by Rowley and Fitch  (27)  on the basis  of the 
transfer of suppression into irradiated rats with cells which have been pretreated 
with anti-SRBC serum, and by Feldmann and Diener (28)  on the basis of the 
inability of mice spleen cell suspensions to respond to the SRBC  or bacterial 
flagellin in vitro or in irradiated recipients after an in vitro pretreatment with 
antigen  and  specific  antiserum.  The  insusceptibility  of  T-cells could be ex- 
plained by their inability to recognize the suppressive signal. 
A  second mechanism involves the  covering of the  antigenic  determinants 
with the suppressing antiserum, thus isolating them from the B-cell precursors. 
This type of mechanism has been proposed by a number of workers in several 
experimental systems based on the ability of antiserum directed against certain 
determinants on a molecule or cell to specifically suppress the response to those 
determinants without affecting the response to other determinants on the same 
molecule or cell (29-31). The ability of T-cells to escape suppression  may be 
explained in such a mechanism by their competing more efficiently than B-cells 
with the suppressing antiserum  for the  antigenic determinants or perhaps by 
their being directed against different determinants than the B-cells. 
The  third  mechanism  explains  the  suppressive  effect  of  antiserum  by its 
causing the rapid elimination of the antigen into phagocytic cells by opsoniza- 
tion.  There is a  considerable body  of evidence in  a  number of experimental 
systems documenting the necessity of 7S (2) cytophilic antibody  (32), with an 
intact Fc portion (33)  of the  molecule, for effective suppression.  In addition, 
the participation of the macrophage in suppression has been demonstrated (34). 
The lack of inhibition of T-cell stimulation could be due to either its interaction 
with the antigen before elimination or by a continued access to the antigen after 
phagocytosis. 
Evaluating these mechanisms on the basis of the results of the experiment 
reported in Table III, the third mechanism emerges as the only one consistent 
with the data. The ability of antibody directed against TNP to suppress the 
development of anti-SRBC-PFC in response to the antigen TNP-SRBC argues 
against a  suppressive mechanism which requires the specific covering of anti- 
genic determinants, or a specific feedback mechanism involving antibody alone. 
In addition, the specific prevention of the suppression of anti-SRBC-PFC by 
free SRBC argues against a suppressive feedback signal by an antigen-antibody 
complex. Although not conclusive, we feel that  the data presented favor the 
elimination of antigen by opsonization as the primary means of suppression of 
the development of PFC in the experiments reported here. 
It is as yet unclear how the antigen-stimulated increase in SRBC-specific T- 
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of T-cells by antigen occurs even in the presence of antibody, as discussed in the 
above mechanisms. However, it is possible that the rapid increase in  SRBC- 
specific T-cells in the spleen which follows immunization is not entirely due to 
proliferation, but is in part also due to the antigen directed "homing" of already 
existing T-cells to lymphoid tissues. Such a homing mechanism would depend on 
the channeling of antigen into the spleen and other lymphoid organs, a process 
which might be expected to be improved rather  than hindered  by antibody. 
The evaluation of this possibility awaits further evidence on the  role of pro- 
liferation in the generation of T-cells in primed mice. 
SUMMARY 
The  effect  of  passively  transfered  antiserum  against  sheep  erythrocytes 
(SRBC)  on the  antigen  stimulated increase of SRBC-specific plaque-forming 
cells  (anfi-SRBC-PFC)  and  SRBC-specific  thymus-derived  lymphocytes 
• (SRBC-specific T-cells) in the mouse spleen was examined. A dose of antiserum 
which severely suppressed the development of anti-SRBC-PFC did not prevent 
the increase in SRBC-specific T-cells, as measured by their ability to cooperate 
in the in vitro response to trinitrophenylated (TNP) SRBC. It was shown that 
the insensitivity of these T-cells to antiserum could not be explained by their 
low antigen requirement as compared to that of PFC. 
In the in vivo response of mice to TNP-SRBC,  antibody specific for TNP 
suppressed  the  appearance  of  both  anti-TNP-  and  anti-SRBC-PFC.  The 
presence of free SRBC specifically prevented the suppression of the anti-SRBC- 
PFC. These observations are consistent with opsonization by phagocytic cells 
as  the  primary means  of  the  observed suppression  of PFC  development by 
antibody. 
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